 |
Key account positioning and messaging |
|
Benchmarking and best practices |
|
Policy analysis |
|
Product launch analysis and planning |
|
Discerning competitors' corporate operations strategies including: |
|
|
|
Benchmarking and analysis of corporate-level, strategic initiatives and operations |
|
Expanding market growth in the BRIC countries: Brazil, Russia, India and China |
|
Opportunities and challenges facing entry into the generics, consumer healthcare
and diagnostics businesses |
|
Approaches for adjusting to pharma's vanishing customer base, the fading gatekeeper
system and major changes to the organization of medical practices |
|
|
Licensing, forecasting, M and A analysis |
|
Due diligence |
|
Market entry opportunities and barriers |
|
Acquisition and co-promotion opportunity analysis |
|
|
| In all the following healthcare segments: |
|
Pharmaceuticals and Biotechnology |
|
Medical devices and diagnostics |
|
Vitamins, nutritionals, OTC products |
|
Providers, hospitals and IPAs |
|
Managed care and PBMs |
